Cargando…

Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO

Detalles Bibliográficos
Autores principales:	Molinaro, Alessandro, Zanta, Daniela, Moleti, Maria Luisa, Giona, Fiorina, Conter, Valentino, Rizzari, Carmelo, Biondi, Andrea, Testi, Anna Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992615/ https://www.ncbi.nlm.nih.gov/pubmed/35444767 http://dx.doi.org/10.4084/MJHID.2022.027

Ejemplares similares

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells
por: de Almeida, Luciana Yamamoto, et al.
Publicado: (2021)

ATO/ATRA/Anthracycline-Chemotherapy Sequential Consolidation Achieves Long-Term Efficacy in Primary Acute Promyelocytic Leukemia
por: Long, Zi-Jie, et al.
Publicado: (2014)

Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)
por: Colita, Andrei, et al.
Publicado: (2023)

Has Hematopoietic Stem Cell Transplantation a Role in the Treatment of Children and Adolescents with Acute Promyelocytic Leukemia?
por: Testi, Anna Maria, et al.
Publicado: (2022)

Penile Ulcer Atra Related in Patient with Acute Promyelocytic Leukemia
por: Yavasoglu, Irfan, et al.
Publicado: (2012)

Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati
por: Balduzzi, Adriana, et al.
Publicado: (2020)

Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021
por: Gill, Harinder, et al.
Publicado: (2023)

An atypical promyelocytic sarcoma and pleural effusion in a patient with Gorham's disease: Efficiency of ATRA/ATO‐based treatment
por: Loyaux, Romain, et al.
Publicado: (2023)

Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia
por: Padovani, Karina Stringhetta, et al.
Publicado: (2021)

FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD)
por: Lo Nigro, Luca, et al.
Publicado: (2022)

Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β
por: Dunoyer-Geindre, Sylvie, et al.
Publicado: (2017)

ATRA-induced bradycardia in a case of acute promyelocytic leukemia: A case report
por: Rathod, Santosh Govind, et al.
Publicado: (2022)

Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells
por: Albanesi, Jacopo, et al.
Publicado: (2020)

MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model
por: Pereira-Martins, Diego A., et al.
Publicado: (2021)

P374: THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009-2017)
por: Mattera, Raffaele, et al.
Publicado: (2023)

Acute Promyelocytic Leukemia (APL): Comparison Between Children and Adults
por: Testi, Anna Maria, et al.
Publicado: (2014)

RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin–proteasome pathway contributes to the reversion of ATRA resistance
por: Yan, Wenzhe, et al.
Publicado: (2019)

Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP)
por: Parasole, Rosanna, et al.
Publicado: (2018)

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study
por: Zhu, Hong-Hu, et al.
Publicado: (2021)

Pediatric Mastocytosis: An Update
por: Giona, Fiorina
Publicado: (2021)

Inhibition of CRL-NEDD8 pathway as a new approach to enhance ATRA-induced differentiation of acute promyelocytic leukemia cells
por: Liu, Shuyuan, et al.
Publicado: (2018)

Advances in Pediatric Acute Promyelocytic Leukemia
por: Conneely, Shannon E., et al.
Publicado: (2020)

ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity
por: Hofmann, Samuel, et al.
Publicado: (2020)

All‐trans retinoic acid (ATRA) in non‐promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low‐dose Ara‐C in three elderly patients with NPM1‐mutated AML unfit for intensive chemotherapy and review of the literature
por: Forghieri, Fabio, et al.
Publicado: (2016)

Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review
por: Testi, Anna Maria, et al.
Publicado: (2023)

Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single‐centre cohort
por: Brivio, Erica, et al.
Publicado: (2022)

Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy
por: Gurnari, Carmelo, et al.
Publicado: (2021)

Thrombocytosis in a male patient with acute promyelocytic leukaemia during all-trans retinoic (ATRA) acid treatment
por: Aldapt, Mahmood B., et al.
Publicado: (2018)

Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
por: Zhang, Xinxin, et al.
Publicado: (2018)

Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
por: Heilmann, Janina, et al.
Publicado: (2023)

Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
por: Rizzari, Carmelo, et al.
Publicado: (2023)

ATRA+ATO combination in APL – A commentary on “evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades” by Teng-Fei et al.
por: Ortaboz, Damla, et al.
Publicado: (2023)

Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020)

Arsenic Trioxide Therapy During Pregnancy: ATO and Its Metabolites in Maternal Blood and Amniotic Fluid of Acute Promyelocytic Leukemia Patients
por: Guo, Meihua, et al.
Publicado: (2022)

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
por: Cario, Gunnar, et al.
Publicado: (2020)

Cuenta atrás
por: Hurwitz, Gregg Andrew
Publicado: (2004)

Hasta atrás
por: Escamilla Monroy, Ruth, et al.
Publicado: (2018)

Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As(2)O(3)) and all-trans retinoic acid (ATRA)
por: Jain, Preetesh, et al.
Publicado: (2018)

P1006: NEXT GENERATION SEQUENCING (NGS) IN PEDIATRIC MASTOCYTOSIS
por: Angi, A., et al.
Publicado: (2022)

Pediatric Acute Promyelocytic Leukemia Presenting to the Emergency Department as Refusal to Ambulate
por: Schwartz, Kevin R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rffj4lj62ugmndljuvff4nfqru